Drug Development

Articles

Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.

J&J Invests in Biologic Manufacturing Capacity Expansion in Ireland

Under an agreement, ProBioGen will develop a stable cell-line for and manufacture an anti-cancer antibody for Chiome using its proprietary cancer cell-killing technology.

ProBioGen and Chiome in Antibody Manufacturing Deal

Under Project BioShield, the agency could provide more than $170 million in funding to purchase and support late-stage development of Ebola vaccines and therapeutic drugs.

BARDA Funds Ebola Vaccine and Drug Development

The Danish biotechnology company has been awarded a sole-source BARDA contract valued at more than $539 million for a freeze-dried smallpox vaccine.

Bavarian Nordic Secures BARDA Contract for Smallpox Vaccine

Virgin Atlantic Cargo and Delta Cargo have opened a new Pharma Zone at their joint facility at London Heathrow Airport for the handling and storage of pharmaceutical shipments.

Virgin Atlantic Cargo, Delta Cargo Unveil New Pharma Zone

A grant from the Bill & Melinda Gates Foundation will advance PnuVax’s pneumonia vaccine’s clinical development and biomanufacturing scale-up using a low-cost manufacturing approach.


PnuVax Receives Grant to Advance Pneumonia Vaccine

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

CDMOs have established strategies for handling new chemical entities with unknown biological activity.

Managing Potentially Potent APIs

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

The pharmaceutical industry is under tremendous pressure to make drug development faster and cheaper. Applying the right formulation strategy using structured and rigorous science can help avoid costly failures and re-starts, but it’s important to start from an early stage.

Starting Early is Key to De-Risking Drug Development

Applying the right formulation strategies early in the drug development process can help avoid costly late-stage failures.

Formulation Strategies in Early-Stage Drug Development

Kevin J. WrigleyÂ is product and service manager, Vetter Pharma International GmbH. 

Choosing between presterilized and bulk sterilized prefilled syringes.

Formulation and Drug Delivery